Niacin extended release (ER)/simvastatin (Simcor®): a guide to its use in lipid regulation.

ABSTRACT: Oral fixed-dose niacin extended release/simvastatin is associated with clinically relevant improvements in plasma lipid profiles, including lowering of non-high-density lipoprotein cholesterol levels, relative to simvastatin monotherapy in patients with mixed dyslipidemias who had not responded fully to simvastatin monotherapy, and is generally well tolerated.

SUBMITTER: Lyseng-Williamson KA 

PROVIDER: S-EPMC3586144 | biostudies-other | 2010

REPOSITORIES: biostudies-other